IMPACT OF INFECTIOUS COMPLICATIONS ON ANTIBODY-MEDIATED REJECTION AFTER ABO-INCOMPATIBLE KIDNEY TRANSPLANTATIONS

被引：0
|
作者：
Kwon, Hyunwook [1 ]
Kim, Young Hoon [2 ]
Kim, Dong Hyun [2 ]
Ko, Youngmin [2 ]
Jung, Joo Hee [2 ]
Han, Duck Jong [2 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[2] Asan Med Ctr, Seoul, South Korea
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
PO360
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [1] Daratumumab for treatment of antibody-mediated rejection after ABO-incompatible kidney transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    [J]. SWISS MEDICAL WEEKLY, 2019, : 14S - 15S
  • [2] Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    [J]. CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2019, 9 (03): : 149 - 157
  • [3] Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations
    Couzi, Lionel
    Manook, Miriam
    Perera, Ranmith
    Shaw, Olivia
    Ahmed, Zubir
    Kessaris, Nicos
    Dorling, Anthony
    Mamode, Nizam
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 (10) : 1205 - 1215
  • [4] REVERSAL OF REFRACTORY ANTIBODY-MEDIATED REJECTION IN ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION BY ECULIZUMAB
    Morath, C.
    Kirschfink, M.
    Waldherr, R.
    Becker, L. E.
    Kihm, L. P.
    Schaier, M.
    Schwenger, V.
    Schmidt, J.
    Hohenfellner, M.
    Leo, A.
    Opelz, G.
    Suesal, C.
    Zeier, M.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 34 - 34
  • [5] ABO Antibody Titer and Risk of Antibody-Mediated Rejection in ABO-Incompatible Renal Transplantation
    Tobian, A. A. R.
    Shirey, R. S.
    Montgomery, R. A.
    Cai, W.
    Haas, M.
    Ness, P. M.
    King, K. E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1247 - 1253
  • [6] The Significance of Microvascular Inflammation in Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.
    Ishihara, H.
    Ishida, H.
    Unagami, K.
    Hirai, T.
    Okumi, M.
    Omoto, K.
    Shimizu, T.
    Tanabe, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 601 - 602
  • [7] Long-term impact of antibody-mediated rejection in ABO-incompatible renal transplantation
    Toki, Daisuke
    Ishida, Hideki
    Tomokazu, Shimizu
    Shirakawa, Hiroki
    Yamaguchi, Yutaka
    Tanabe, Kazunari
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 272 - 272
  • [8] Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
    de Weerd, Annelies
    Vonk, Alieke
    van der Hoek, Hans
    van Groningen, Marian
    Weimar, Willem
    Betjes, Michiel
    van Agteren, Madelon
    [J]. BMC NEPHROLOGY, 2014, 15
  • [9] Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
    Annelies de Weerd
    Alieke Vonk
    Hans van der Hoek
    Marian van Groningen
    Willem Weimar
    Michiel Betjes
    Madelon van Agteren
    [J]. BMC Nephrology, 15
  • [10] Case Report: Eculizumab Rescue of Severe Accelerated Antibody-Mediated Rejection After ABO-Incompatible Kidney Transplant
    Stewart, Z. A.
    Collins, T. E.
    Schlueter, A. J.
    Raife, T. I.
    Holanda, D. G.
    Nair, R.
    Reed, A. I.
    Thomas, C. P.
    [J]. TRANSPLANTATION PROCEEDINGS, 2012, 44 (10) : 3033 - 3036
12345